ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1381

Association of Omeract Core Domains of Pain and Function with Patient Satisfaction after Total Joint Replacement

Susan M. Goodman1, Bella Y. Mehta2, Lisa A. Mandl3, Jackie Szymonifka1, Mark P. Figgie4, Iris Navarro-Millán5, Mathias Bostrom6, Michael L. Parks7, Alexander McLawhorn8, Stephen Lyman7 and Jasvinder A. Singh9, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery/Weill Cornell Medicine/Mailman School of Public Health, New York, NY, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Surgery, Hospital for Special Surgery, New York, NY, 5Weill Cornell Medicine, New York, NY, 6Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, 7Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 8Hospital for Special Surgey, New York, NY, 9Rheumatology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: functional status, outcomes, pain and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Up to 20% of Total Joint Replacement (TJR) patients are dissatisfied, but this is difficult to study as it is challenging to pool data due to the lack of unified core outcome measures.  The OMERACT TJR Working Group has recently endorsed a core domain set for Knee and Hip TJR trials that include pain, function and patient satisfaction among others, and now seeks validation prior to development of a TJR trial core measurement set. We aim to assess the association of pain relief and improved function with patient satisfaction 2 years after TJR.

Methods:  We identified all patients undergoing total hip (THR) and knee (TKR) replacement enrolled in a hospital-based registry from 2007-2011, and evaluated those with 2-year satisfaction scores. Pain and function were measured using the Knee and Hip injury and Osteoarthritis Outcome Score (KOOS, HOOS) and satisfaction was measured using 5 primary questions, each rated on a Likert scale.  Each question was weighted equally and a satisfaction summary score was calculated (range 0-100, higher scores corresponding to greater satisfaction). Expectations were measured using the validated HSS Expectations survey. Correlation was analyzed with Spearman coefficients, and scores were compared by quartiles using the Kruskal-Wallis test. Rasch modeling was attempted but a unidimensional construct could not be achieved.

Results: We included 4,796 primary unilateral TKR and 4801 THR. 78% of TKR and 90.7% of THR were very satisfied with pain relief, and 6.5% of TKR and 2.5 % of THR were somewhat or very dissatisfied (Table 1). Satisfaction correlated moderately with pain (TKR ρ=0.61, THR ρ=0.47) and function (TKR ρ=0.65, THR ρ=0.51) at 2 years; there was no correlation with baseline expectations. When comparing satisfaction by pain, function and expectation quartiles, there were statistically significant differences (Table 2); those with the best scores and greatest change in pain and function were the most satisfied.

Conclusion: These findings confirm that with increasing relief of pain and functional improvement, the strength of the association of 2 core domains with satisfaction increases, further validating these core domains for use in TJR clinical trials. The range of correlation of satisfaction measure of 0.47-0.61 with pain and function, indicates that satisfaction domain is somewhat independent of pain and function, further validating its inclusion in the core domain set. A core outcome measurement set needs to be defined for use in TJR clinical trials that includes validated measures of these domains.

 

 

 


Disclosure: S. M. Goodman, Roche, Novartis, 4; B. Y. Mehta, None; L. A. Mandl, None; J. Szymonifka, None; M. P. Figgie, None; I. Navarro-Millán, None; M. Bostrom, NIH/NIAMS Research Grant #R21 AR071534, 2,Consultant for Smith Nephew, 5; M. L. Parks, Zimmer Biomet, 2, 5; A. McLawhorn, Ethicon and Intellijoint, 5; S. Lyman, None; J. A. Singh, Takeda, Savient, 2,Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta/Horizon and Allergan pharmaceuticals, WebMD, UBM LLC, Medscape , Fidia pharmaceuticals and the American College of Rheumatology, 5.

To cite this abstract in AMA style:

Goodman SM, Mehta BY, Mandl LA, Szymonifka J, Figgie MP, Navarro-Millán I, Bostrom M, Parks ML, McLawhorn A, Lyman S, Singh JA. Association of Omeract Core Domains of Pain and Function with Patient Satisfaction after Total Joint Replacement [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/association-of-omeract-core-domains-of-pain-and-function-with-patient-satisfaction-after-total-joint-replacement/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-omeract-core-domains-of-pain-and-function-with-patient-satisfaction-after-total-joint-replacement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology